Injective
2 open NYC jobs
Injective is a specialized blockchain designed for Web3 finance, focusing on decentralized finance (DeFi), real-world asset tokenization, and AI-driven financial applications. Founded in 2018 by Eric Chen and Albert Chon, the company operates under Injective Labs, a research and development firm based in New York City. It has received support from notable investors like Jump Crypto and Mark Cuban.
As a Layer 1 blockchain, Injective features a native decentralized orderbook, enabling permissionless trading with zero gas fees. It supports cross-chain interoperability with major networks such as Ethereum, Solana, and Cosmos, allowing seamless liquidity and asset movement. The platform offers a suite of services, including a decentralized exchange called Helix, and tools for developers to create various financial applications efficiently. The native utility token, INJ, plays a crucial role in governance, staking, and transaction fees within the ecosystem.